India patient India

Glenmark launches antiviral drug Favipiravir, trials show encouraging results in patients with mild to moderate Covid

Reading now: 336
www.livemint.com

Join Livemint channel in your Telegram and stay updated

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA